The Weizmann Institute of Science in Rehovot, Israel, has devised a
noninvasive technique for diagnosing whether a tumour is benign or malignant. A
contrast-enhancing dye is injected into the patient’s bloodstream and magnetic
resonance imaging is used to watch it pass through the tumour. The spaces
between cells and the presence or absence of blood vessels determine the rate at
which the dye passes through. In benign tumours the dye accumulates and washes
out slowly, but in malignant cancers it passes straight through.
More from New Scientist
Explore the latest news, articles and features
Technology
US government wants to have a useful quantum computer by 2028
News
Life
Childbirth for many primate species is even harder than for humans
News
Humans
Humans sleep the least of all apes – is it the secret to our success?
Features
91É«ÇéƬ
Your menstrual cycle may affect how well vaccines work
News
Popular articles
Trending New Scientist articles
1
Where, when and how to watch the 2026 solar eclipse
2
Humans sleep the least of all apes – is it the secret to our success?
3
Remote-controlled cockroach swarm can now breathe underwater
4
We’ve uncovered a master gene that switches on human development
5
Childbirth for many primate species is even harder than for humans
6
US government wants to have a useful quantum computer by 2028
7
Our verdict on The Selfish Gene: An unpopular piece of popular science
8
Fully autonomous drones have killed human soldiers for the first time
9
How menopause radically changes the brain – and what happens after
10
Europe’s heatwave is the hottest and most humid ever
